Home » Novartis Seeks to Broaden Use of Some Cancer Drugs
Novartis Seeks to Broaden Use of Some Cancer Drugs
Novartis, the Basel health-care giant, said on Wednesday that this month, it would
ask regulators to clear two already marketed drugs, Tasigna and Zometa, to treat a broader range of cancers.
MarketWatch
MarketWatch
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May